Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease - Wallentin_2016_J.Am.Heart.Assoc_5_ |
| Author(s) : Wallentin L , Held C , Armstrong PW , Cannon CP , Davies RY , Granger CB , Hagstrom E , Harrington RA , Hochman JS , Koenig W , Krug-Gourley S , Mohler ER, 3rd , Siegbahn A , Tarka E , Steg PG , Stewart RA , Weiss R , Ostlund O , White HD |
| Ref : J Am Heart Assoc , 5 : , 2016 |
| Abstract : Wallentin_2016_J.Am.Heart.Assoc_5_ |
| ESTHER : Wallentin_2016_J.Am.Heart.Assoc_5_ |
| PubMedSearch : Wallentin_2016_J.Am.Heart.Assoc_5_ |
| PubMedID: 27329448 |
| Title : Peripheral artery disease, biomarkers, and darapladib - Berger_2011_Am.Heart.J_161_972 |
| Author(s) : Berger JS , Ballantyne CM , Davidson MH , Johnson JL , Tarka EA , Lawrence D , Trivedi T , Zalewski A , Mohler ER, 3rd |
| Ref : American Heart Journal , 161 :972 , 2011 |
| Abstract : Berger_2011_Am.Heart.J_161_972 |
| ESTHER : Berger_2011_Am.Heart.J_161_972 |
| PubMedSearch : Berger_2011_Am.Heart.J_161_972 |
| PubMedID: 21570531 |
| Title : Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development - Wilensky_2008_Nat.Med_14_1059 |
| Author(s) : Wilensky RL , Shi Y , Mohler ER, 3rd , Hamamdzic D , Burgert ME , Li J , Postle A , Fenning RS , Bollinger JG , Hoffman BE , Pelchovitz DJ , Yang J , Mirabile RC , Webb CL , Zhang L , Zhang P , Gelb MH , Walker MC , Zalewski A , Macphee CH |
| Ref : Nat Med , 14 :1059 , 2008 |
| Abstract : Wilensky_2008_Nat.Med_14_1059 |
| ESTHER : Wilensky_2008_Nat.Med_14_1059 |
| PubMedSearch : Wilensky_2008_Nat.Med_14_1059 |
| PubMedID: 18806801 |
| Gene_locus related to this paper: human-PLA2G7 |
| Title : The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study - Mohler_2008_J.Am.Coll.Cardiol_51_1632 |
| Author(s) : Mohler ER, 3rd , Ballantyne CM , Davidson MH , Hanefeld M , Ruilope LM , Johnson JL , Zalewski A |
| Ref : J Am Coll Cardiol , 51 :1632 , 2008 |
| Abstract : Mohler_2008_J.Am.Coll.Cardiol_51_1632 |
| ESTHER : Mohler_2008_J.Am.Coll.Cardiol_51_1632 |
| PubMedSearch : Mohler_2008_J.Am.Coll.Cardiol_51_1632 |
| PubMedID: 18436114 |